This episode is part of a limited series called Money Ball in conjunction with the BLPN Club . BLPN's Money Ball program helps founders step up to the plate and knock fundraising out of the park. You'll hear about the people, their ventures, and their pitch-making experiences.

In this episode of The Healthy Enterprise, host Heath Fletcher speaks with Chandi Bandara, CEO of Precision Quantomics, about the challenges and innovations in drug development. They discuss the inefficiencies in the pharmaceutical industry, the importance of effective pitching to investors, and the insights gained from the Money Ball program. Chandi shares his journey from a molecular biologist to a CEO, the lessons learned in storytelling for pitches, and the significance of feedback in refining business strategies. The conversation emphasizes the need for entrepreneurs to seek guidance and input from experienced peers in their journey.

Chapters:
00:00 Introduction to The Healthy Enterprise and Money Ball Series
00:39 Chandi Bandara: CEO of Precision Quantomics
02:04 Innovative Solutions in Drug Development
03:49 Company Progress and Market Presence
05:07 Chandi's Journey to Precision Quantomics
06:26 The Art of Pitching to Investors
09:00 Crafting the Perfect Pitch Story
11:28 Refining the Pitch with Money Ball Program
13:30 Learning from Investor Feedback
15:22 Common Mistakes in Pitching
18:17 Unique Perspective as a Non-Founder CEO
20:03 Impact of Money Ball Program on Pitching
22:28 Advice for Aspiring Entrepreneurs
25:54 Conclusion and Future Aspirations

Guest Information:

• Guest's Name: Chandi Bandara
• Guest's Title/Position:  Chief Executive Officer
• Guest's Linkedin: https://www.linkedin.com/in/cabandara/
• Company / Affiliation: Precision Quantomics https://precisionquantomics.com/
• Guest's Bio:  Chandima Bandara is CEO of Precision Quantomics, where he leads the company’s mission to transform drug development through high-precision proteomics. With more than 20 years of experience across biotechnology, contract research, business development, and large-scale operations, he brings a unique blend of scientific expertise and operational leadership to the biotech industry.
  He began his career in R&D before scaling growth at a leading CRO and later managing world-class logistics operations at Amazon. Over the past six years, he has focused on commercializing scientific innovation through life sciences startups. At Precision Quantomics, he is building a comprehensive proteomics database, LC-MS kit portfolio, and testing-as-a-service platform to accelerate pharmaceutical R&D and reduce costs. Chandima also serves on the Board of Trustees for the Health Sciences & Services Authority of Spokane County and contributes to national initiatives advancing regulatory science and New Approach Methodologies.

Takeaways:

• Precision Quantomics addresses inefficiencies in drug development.
• 90% of drugs fail to reach the market due to outdated models.
• Chandi Bandara transitioned from science to business development.
• Effective pitching requires understanding the audience's perspective.
• The Money Ball program helped refine Chandi's pitch.
• Investors need to hear the problem and solution quickly.
• Iterating on the pitch deck is crucial for success.
• Feedback from investors is invaluable for improvement.
• Every entrepreneur's journey is unique and requires tailored advice.
• Building a supportive ecosystem is essential for startup growth.